Cardiometabolic Health Congress

As part of a multi-institutional effort, researchers in the fields of proteomics, lipidomics, and metabolomics will collaborate to discover more effective ways of predicting which patients with type 1 diabetes are at greater risk for developing kidney disease.

Researchers in Australia recently reported that the immune signaling protein NLRP1 plays a key role in metabolism by activating fat-burning processes when the body's energy intake is too high.

There are approximately 500,000 new cases of heart disease every year, and with heart failure being a potential complication in many of those cases, effective therapies are necessary.

Hyperkalemia can be fatal and there is a serious need to provide improved treatment options.

When blood pressure remains high despite the use of three antihypertensive agents, a resistant hypertension diagnosis can be made. Well-known treatments are available, but novel approaches are showing promise.

Study results show asthma severity can be controlled with weight loss in obese patients.

At the 2015 Cardiometabolic Health Congress, Christie M. Ballantyne, MD, moderated a panel discussion focusing on current cholesterol guidelines and several changes that may be coming soon.

Lipid resuscitation therapy was identified in 1998 as an effective treatment for local anesthetic systemic toxicity. Since then, researchers have developed a better understanding of the risk factors involved and the manner in which lipids work, using both dynamic scavenging and direct cardiotonic effects.

Elevated levels of triglycerides have been proven time and time again to be linked to cardiovascular disease. While it can be a challenging condition to control, it opens the door for treatments.

It wasn't long ago that researchers first identified a piece of DNA that regulates cholesterol. This gene has been recently developed into a cholesterol-lowering agent and it's time to address where we go from here.

Type 1 diabetes mellitus (T1DM) is treated by necessity with insulin analogues in an attempt to mimic normal physiological insulin profiles. Regardless, this approach is rarely completely successful and most T1DM patients experience fluctuating or suboptimal glucose control, significant hypoglycemia and microvascular tissue complications.

Most adults in developed nations struggle with their weight. Ample quantities of high-quality foods (and plenty of sugar- and fat-laden snacks) do more than just nourish us. They allow us to overindulge; in fact, they tend to make people eat mindlessly.

Patients with early rheumatoid arthritis may have reduced myocardial and vascular function.

Researchers continue to look at the age-old question of when to stop treatment with antiplatelet drugs if surgery is necessary. Stopping them too soon increases risk of clotting. Stopping them too late increases risk of excessive blood loss.

The 2013 revision of guidelines on managing overweight and obesity in adults suggests that providers and patients set a goal of a sustained weight loss of 3-5% of baseline body weight to obtain improvements in triglycerides, blood glucose, HbA1c, and the risk of developing type 2 diabetes mellitus.

Individuals who engage in physical activity on a regular basis have improved cardiovascular fitness, improved insulin sensitivity, and improved glucose tolerance.

Patients who are overweight or obese have several medication options as an adjunct to lifestyle modification for weight loss.

App will help patients with diabetes log their hypoglycemic events and achieve better control of these events by becoming more aware of preceding signs and symptoms.

Provocative research raises the question of whether we should we look at Alzheimer's disease as "type 3 diabetes."

Presentation at CMHC 2014 provides updates on emerging classes of diabetes treatment, including preliminary data from current clinical trials.

Recent studies of targeted anti-inflammatory therapy show promise for helping patients with high blood pressure and elevated cholesterol levels.

Advances in treatment could provide much needed help for patients with obesity, diabetes, and hypertension

Should measures of lipoprotein levels and LDL particle size be taken into account when treating cardiometabolic issues?

Allen Taylor, MD, explained the benefits of using niacin in the treatment of high cholesterol during a debate at the Cardiometabolic Health Congress.

In a debate at the Cardiometabolic Health Congress on the lipid-lowering benefits of niacin vs. fibrates, Henry Ginsberg, MD, made the case for fibrates.

At the Cardiometabolic Health Congress, Daniel Rader, MD, explained why raising HDL cholesterol may be pivotal to improving cardiovascular health.

In his presentation, James Gavin III, MD, describes why he thinks the current approach to diabetes treatment is failing.

Steven Lipschultz, MD, presented information on current research in pediatric heart health and discussed early interventions.

Successfully treating hypertension benefits diabetes management and may help prevent cardiovascular events.

Herald Lebovitz describes effective treatments in preventing diabetes in patient with impaired glucose control.